Opinion|Videos|August 9, 2024
MDMA-Assisted Therapy: Providing the Brain With a Necessary Boost
Author(s)John J. Miller, MD
The Psychiatric Times editor-in-chief shares perspectives on how a novel treatment, MDMA-assisted therapy, can potentially change the treatment landscape and improve patients’ lives.
Advertisement
Episodes in this series
Advertisement
Related to this article
Explore PTSD prevalence, comorbidities, and first-line care as we invite clinicians to share cases and research.
How VA clinicians treat veterans’ PTSD while managing suicide risk, using shared decisions, safety planning, and phase-based trauma therapies.
Advertisement
Advertisement
Trending on Psychiatric Times
1
Olanzapine LAI (Weltruza) Receives FDA Approval for Schizophrenia
2
Clozapine Remains Underused After REMS Elimination: A Conversation With Jose Rubio, MD, PhD
3
FDA Grants Clearance to Motivista, the First Authorized Treatment for Negative Symptoms of Schizophrenia
4
Phase 1 Clinical Studies Completed: NTX-253 for the Treatment of Schizophrenia
5